Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:acquisitionYear |
2018
|
| gptkbp:country |
gptkb:Belgium
|
| gptkbp:focusesOn |
regenerative medicine
stem cell therapy |
| gptkbp:foundedIn |
2000
|
| gptkbp:founder |
Eduardo Bravo
|
| gptkbp:headquartersLocation |
gptkb:Leuven
|
| https://www.w3.org/2000/01/rdf-schema#label |
TiGenix
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:Euronext_Brussels
|
| gptkbp:notableProduct |
Cx601
|
| gptkbp:bfsParent |
gptkb:Takeda
gptkb:Takeda_(Japan) |
| gptkbp:bfsLayer |
6
|